注册并分享邀请链接,可获得视频播放与邀请奖励。

IPO Newsroom
@IPONewsroom_
Your IPO newsroom. S-1 filings, pricing updates, debut coverage, and post-IPO performance.
加入 November 2024
109 正在关注    32K 粉丝
Samsung Biologics' $2 billion rights offering was oversubscribed more than five times, drawing bids for 11.9 million shares against 2.3 million offered. The proceeds help fund its acquisition of PolyPeptide, per Dow Jones.
显示更多